Brickwood Asset Management LLP Acquires 1,496,935 Shares of DENTSPLY SIRONA Inc. $XRAY
Brickwood Asset Management LLP significantly increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5,515.8% in Q3, acquiring 1,496,935 shares and now holding 1,524,074 shares worth $19.34 million. This makes DENTSPLY SIRONA its 5th largest holding, representing 14.7% of its portfolio. Other institutional investors also added to their positions, indicating strong institutional interest despite mixed analyst ratings and an upcoming earnings report that could create volatility.
Dentsply Sirona announces new webinars on implant dentistry
Dentsply Sirona is introducing two new webinars on its Dentsply Sirona Academy Campus focusing on implant dentistry. The first webinar, "Prosthetic dentistry in the digital era," will explore the impact of AI and cloud-based platforms on prosthetic workflows, presented by Prof. Stefan Vandeweghe. The second, "Managing implant restoration complications," will guide clinicians on identifying and addressing common issues, led by Dr. Varisha Parikh.
DENTSPLY SIRONA (NASDAQ:XRAY) Shares Gap Up on Analyst Upgrade
DENTSPLY SIRONA (NASDAQ:XRAY) shares gapped up after Bank of America upgraded the stock from a "neutral" to a "buy" rating, raising its price target from $13 to $17. The stock opened at $13.12, up from its previous close of $12.49. Despite the upgrade, analyst coverage remains mixed with an average "Hold" rating and a target price of $14.46 across various research firms.
Dentsply Sirona stock upgraded to Buy at BofA (XRAY:NASDAQ)
Bank of America has upgraded Dentsply Sirona's (XRAY) stock from Neutral to Buy, increasing its price target to $17 from $13. The upgrade is attributed to a compelling risk-reward opportunity for the dental product manufacturer. Following this news, shares of Dentsply Sirona traded higher on Thursday.
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Upgraded by Bank of America
Bank of America has upgraded DENTSPLY SIRONA (NASDAQ:XRAY) from "neutral" to "buy" and increased its price target to $17, suggesting a 36.11% upside. Other analysts have varying opinions, leading to a consensus "Hold" rating with an average price target of $14.46. Insider sales and institutional ownership figures are also detailed in the report.
Dentsply Sirona stock rating upgraded to buy by BofA on valuation
BofA Securities upgraded Dentsply Sirona (NASDAQ:XRAY) stock from Neutral to Buy, raising its price target to $17 from $13 due to perceived undervaluation and a positive risk/reward profile. The upgrade is based on BofA's expectation that the dental equipment maker's valuation gap with peers will narrow in 2026, driven by new management's progress in distributor relationships and potential multiple expansion. The firm also noted recent significant developments including renewed distribution agreements and leadership appointments.
Heartland Advisors Inc. Sells 214,126 Shares of DENTSPLY SIRONA Inc. $XRAY
Heartland Advisors Inc. reduced its stake in DENTSPLY SIRONA Inc. by 14% in the third quarter, selling 214,126 shares and ending with 1,312,207 shares valued at approximately $16.65 million. This move comes as analysts have largely lowered price targets and maintained "Reduce" or "Hold" ratings for the dental equipment supplier, with an average price target of $14.25. Insider selling also occurred, with Director Gregory T. Lucier selling 82,200 shares.
Cibc World Market Inc. Cuts Stake in DENTSPLY SIRONA Inc. $XRAY
Cibc World Market Inc. reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 42.0% in Q3 2025, selling 388,618 shares and ending the quarter with 536,540 shares valued at approximately $6.81 million. Analyst sentiment for DENTSPLY SIRONA is generally weak, with a consensus rating of "Reduce" and an average price target of $14.25, while insider selling by Director Gregory T. Lucier was also noted. The company also announced a quarterly dividend of $0.16 per share, yielding about 4.9% annually.
Advisors Asset Management Inc. Boosts Stock Holdings in DENTSPLY SIRONA Inc. $XRAY
Advisors Asset Management Inc. increased its stake in DENTSPLY SIRONA Inc. (XRAY) by 42.8% in Q3, now owning 348,989 shares valued at $4.43 million, contributing to institutional investors holding 95.70% of the company. Despite this, analysts have lowered price targets and issued a consensus "Reduce" rating for XRAY, with an average target of $14.25. Additionally, director Gregory T. Lucier sold 82,200 shares, while the company maintains a quarterly dividend of $0.16, yielding approximately 4.9%.
Inside the Dentsply Sirona Ruling: Which Claims Moved Forward—and Why
A U.S. District Court recently ruled on a securities fraud case against Dentsply Sirona, allowing several claims related to alleged misstatements about its Byte direct-to-consumer aligner business, regulatory compliance, and growth characterization to proceed, while dismissing others. The ruling highlights the stringent pleading standards of the Private Securities Litigation Reform Act (PSLRA) and emphasizes that such decisions are based on pleading-stage determinations, not findings of fact. The court dismissed all claims against the former CFO due to insufficient evidence of scienter, but found strong inference of scienter for the company and other individual defendants, allowing claims related to misleading doctor oversight representations, screening practices, regulatory compliance, and growth characterization to move forward.
Dental Impression Systems Market Size, Share | Forecast [2034]
The global dental impression systems market, valued at USD 1.85 billion in 2025, is projected to reach USD 3.30 billion by 2034, growing at a CAGR of 6.7%. This growth is driven by increasing demand for dental treatments, technological advancements, and a significant shift from traditional to digital impression systems. Key market players like Dentsply Sirona and Align Technology are focusing on innovation and strategic partnerships to capitalize on these opportunities.
Allianz Asset Management GmbH Has $17.20 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY
Allianz Asset Management GmbH significantly increased its stake in DENTSPLY SIRONA Inc. by 63.6% in the third quarter, now owning 1,355,643 shares valued at approximately $17.2 million. Other institutional investors also adjusted their positions in the medical instruments supplier. DENTSPLY SIRONA recently missed its Q3 earnings expectations, reported a revenue decrease, and has an average analyst rating of "Reduce."
Dental Equipment Market is expected to reach US$ 12.4 billion
The global Dental Equipment Market is projected to grow from US$ 6.8 billion in 2024 to US$ 12.4 billion by 2033, exhibiting a CAGR of 7.0%. This growth is driven by increasing oral health awareness, technological advancements, demand for cosmetic dentistry, and improvements in dental care infrastructure. Key players in this market include Henry Schein, Dentsply Sirona, and 3M.
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to discuss its fourth quarter and full year 2025 financial results. The company will release a press statement and financial presentation on its investor website prior to the call. Interested parties can register online for the webcast or access a replay afterwards.
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26
Dentsply Sirona (Nasdaq: XRAY) is scheduled to host an investor conference call and live webcast on February 26, 2026, at 4:30 p.m. EST to discuss its fourth quarter and full year 2025 financial results. A press release and presentation with summary financial information will be made available on the company's investors website prior to the call, with a webcast replay accessible afterward. Dentsply Sirona is a leading global manufacturer of professional dental products and technologies.
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26
Dentsply Sirona (Nasdaq: XRAY) announced it will host an investor conference call and live webcast on February 26, 2026, at 4:30 p.m. EST to discuss its fourth quarter and full year 2025 financial results. A press release and presentation will be available on the company's investors website prior to the call. The webcast replay will also be accessible on the website.
Is Weak Revenue And ROIC Undermining The Investment Case For DENTSPLY SIRONA (XRAY)?
Dentsply Sirona (XRAY) is facing challenges with declining revenue and weakening return on invested capital, raising concerns about its investment narrative. Despite a "Return to Growth" plan, recent quarterly results suggest a focus on repair rather than acceleration, with the company's dividend not comfortably covered amidst losses and execution risk. Investors are cautioned that the stock might still be overvalued, and a range of fair value estimates highlights diverse expectations for its future.
Mitsubishi UFJ Trust & Banking Corp Purchases 100,468 Shares of DENTSPLY SIRONA Inc. $XRAY
Mitsubishi UFJ Trust & Banking Corp significantly increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,836.7%, acquiring an additional 100,468 shares to own a total of 105,938 shares valued at approximately $1.34 million. This comes as DENTSPLY SIRONA reported Q4 earnings that missed expectations and provided a cautious FY2025 guidance. The stock currently has a "Reduce" consensus rating from analysts with an average price target of $14.83.
A Look At Dentsply Sirona (XRAY) Valuation After Recent Share Price Rebound
Dentsply Sirona (XRAY) has seen a recent rebound in its share price, with a 9.1% increase over the past month. Despite a 33.81% decline over the past year, the stock is currently trading at $12.47, implying a roughly 59% discount to its intrinsic value. Analysts estimate its fair value at $12.97, suggesting it is slightly undervalued, with active cost reduction programs expected to boost EBITDA and cash flow.
Y Intercept Hong Kong Ltd Has $1.30 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY
Y Intercept Hong Kong Ltd has significantly reduced its stake in DENTSPLY SIRONA Inc. by 57.1% during Q3, now holding 102,195 shares valued at approximately $1.30 million. This move comes as Director Gregory T. Lucier also sold a substantial number of shares, and analysts have adopted a cautious stance with a "Reduce" consensus rating and an average price target of $14.83 for XRAY. The company's recent earnings report showed a miss on EPS and a decline in year-over-year revenue.
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings?
Dentsply Sirona (XRAY) has seen a significant 23.6% drop in its stock price over the last six months, trading at $12.31, largely due to weaker Q3 earnings. Analysts advise caution, highlighting declining constant currency revenue, a negative five-year average return on invested capital (ROIC) of -9.5%, and further decreases in ROIC indicating a lack of profitable growth opportunities. Despite its optically cheap 8.5x forward P/E, concerns about shaky fundamentals suggest better investment opportunities exist elsewhere.
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings?
This article analyzes Dentsply Sirona (XRAY) post its Q3 earnings, suggesting investors hold off on buying despite a 23.6% stock drop. The cautious stance is based on declining constant currency revenue, negative return on invested capital (ROIC) over five years, and a further decline in ROIC indicating a lack of profitable growth opportunities. The author concludes that while the stock appears cheap at 8.5x forward P/E, its shaky fundamentals present significant potential downside.
Dentsply Sirona Inc (XRAY) Trading Down 3.05% on Jan 28
Dentsply Sirona Inc (XRAY) shares fell 3.05% on January 28, trading at $12.38. This places the stock significantly below its 52-week high, although above its 52-week low. Wall Street analysts have an average target price of $12.75, implying a slight upside, while GuruFocus estimates a significantly higher GF Value of $27.65.
Cooke & Bieler LP Decreases Stake in DENTSPLY SIRONA Inc. $XRAY
Cooke & Bieler LP reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.9% in the third quarter, now holding 8,522,989 shares valued at approximately $108.16 million. This follows mixed operating results, where the company missed Q3 EPS estimates and saw a revenue decrease but announced a quarterly dividend. Analysts hold a "Reduce" consensus rating with an average price target of $14.83, while some institutional investors have increased their positions.
Dental News - DENTSPLY–Sirona merger to create world's largest dental manufacturer
The article "Dental News - DENTSPLY–Sirona merger to create world's largest dental manufacturer" is actually a placeholder title on a dental news aggregator website. The content provided is a list of recent dental news articles, interviews, editorials, and event announcements, indicating ongoing activities and developments in the dental industry. It features various topics from professional events like CIOSP 2026 and AEEDC Dubai to advancements in dental technology, education, and public health initiatives.
The Truth About Dentsply Sirona Inc: Wall Street Sleeper or Next Big Health-Tech Play?
The article analyzes Dentsply Sirona Inc (DENT), a dental technology giant, assessing its potential as an investment. It highlights the company's crucial role in digital dentistry and its stable, recurring demand, contrasting it with more volatile meme stocks. The piece concludes that DENT is a "considered cop" for long-term investors seeking healthcare exposure, rather than a short-term, hype-driven play.
Lobbying Update: $20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed
DENTSPLY SIRONA INC. (XRAY) recently disclosed $20,000 in lobbying expenditures for Q4 2025, focused on issues like "Competitive bidding for urological products, trace and tariffs." The article also details recent insider trading activity, with one sale and one purchase, and significant institutional investor movements in XRAY stock. Analysts have issued "Outperform" and "Buy" ratings with a median price target of $13.0 among nine analysts.
Dental Market Dynamics and Contributions by Dentsply Sirona,
The dental market is experiencing significant growth driven by technological advancements like digital dentistry, AI integration, and customization. Key players such as Dentsply Sirona, Danaher, and 3M are contributing to innovations in dental consumables and equipment. Despite opportunities in untapped niches and telehealth, challenges include regulatory hurdles and supply chain gaps, requiring proactive strategies from industry stakeholders.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), DENTSPLY SIRONA (XRAY) and Exact Sciences (EXAS)
Analysts have issued mixed ratings for three healthcare companies: Agilent (A), DENTSPLY SIRONA (XRAY), and Exact Sciences (EXAS). Agilent received a Strong Buy consensus, DENTSPLY SIRONA a Hold, and Exact Sciences also a Hold, reflecting varying price targets and outlooks from different financial institutions.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), DENTSPLY SIRONA (XRAY) and Exact Sciences (EXAS)
Analysts have issued conflicting ratings for several healthcare companies. Agilent (A) received a Strong Buy consensus, with HSBC initiating coverage with a Buy rating. DENTSPLY SIRONA (XRAY) maintained a Hold consensus, although some analysts recently upgraded their stock to a Hold. Exact Sciences (EXAS) received a Hold consensus, with Mizuho Securities downgrading the stock to Hold.
Dental Market Overview and Leading Players: Dentsply Sirona,
The dental market is a crucial and evolving sector, driven by technological advancements like AI and 3D printing, and increasing consumer demand for comprehensive oral health solutions. Key growth drivers include sustainability, digitization, personalized treatment, and emerging technologies like AI, IoT, and virtual reality. The market is segmented by type (consumables, equipment) and application (hospitals, clinics), with major players including Dentsply Sirona, Danaher, and Align Technology, all adapting to new opportunities and tackling challenges like regulatory hurdles and supply chain disruptions.
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know
Shares of Dentsply Sirona (NASDAQ: XRAY) rose 3.8% after Mizuho analyst Steven Valiquette increased the price target for the stock from $13.00 to $14.00, maintaining a "Neutral" rating. The analyst's increased price target suggests a more positive outlook on the company's future stock value, contributing to the stock's rise. Despite the recent gain, the stock is still trading significantly below its 52-week high from January 2025.
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know
Shares of Dentsply Sirona (NASDAQ:XRAY) jumped 3.8% after Mizuho analyst Steven Valiquette raised the price target on the stock to $14.00 from $13.00, while maintaining a "Neutral" rating. The analyst's increased price target suggests a more positive outlook for the company's future stock value, even without a formal rating upgrade. The stock is up 11.6% year-to-date, despite trading significantly below its 52-week high from January 2025.
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Campbell & CO Investment Adviser LLC
Campbell & CO Investment Adviser LLC significantly reduced its stake in DENTSPLY SIRONA (NASDAQ:XRAY) by 67.6% in the third quarter, selling 122,486 shares and retaining 58,655 shares valued at $744,000. Analyst sentiment for DENTSPLY SIRONA is generally mixed-to-negative, with an average "Reduce" rating and a consensus target price of $15.23 after the company missed Q3 earnings estimates. The company also announced a quarterly dividend of $0.16 per share, yielding 5.3%, and insiders have recently sold shares.
Is Dentsply Sirona (XRAY) Pricing Reflect Recent Slide In Dental Equipment Sentiment Accurately
Dentsply Sirona (XRAY) appears undervalued according to Simply Wall St's analysis, with its share price trading at a significant discount to its estimated intrinsic value based on Discounted Cash Flow (DCF) analysis and a lower-than-average Price-to-Sales (P/S) ratio compared to industry peers. The article highlights that despite recent shifts in sentiment towards healthcare suppliers, the company's valuation metrics suggest it could be a buy. Investors are encouraged to explore their own narratives and assumptions regarding the company's future performance.
A Look At Dentsply Sirona (XRAY) Valuation After Renewed Patterson And Expanded Benco Distribution Deals
Dentsply Sirona (XRAY) is back in focus following renewed distribution deals with Patterson Dental and an expanded partnership with Benco Dental, covering its full digital portfolio. Despite a recent 6.82% monthly stock increase, its one-year total shareholder return is down 31.77%, leading to questions about its valuation. The company is currently estimated to be slightly undervalued, with a fair value close to its current share price, but risks remain if revenue softness and cost pressures persist.
Dentsply Sirona Inc - Co And Patterson Dental Renew U.S. Dental Technology Distribution Agreement - SEC Filing
Dentsply Sirona Inc. and Patterson Dental have renewed their U.S. Dental Technology Distribution Agreement, as disclosed in an SEC filing. This agreement pertains to the distribution of dental technology products. The news is brief and notes that the information is copyrighted by Thomson Reuters.
Nordea Investment Management AB Purchases 142,451 Shares of DENTSPLY SIRONA Inc. $XRAY
Nordea Investment Management AB increased its stake in DENTSPLY SIRONA Inc. by 33.3% during the third quarter, acquiring an additional 142,451 shares to hold a total of 570,466 shares valued at approximately $7.19 million. This occurred amidst weakening Wall Street sentiment, with the company missing Q3 EPS estimates and issuing lower-than-expected FY2025 guidance, leading to an average "Reduce" rating from analysts. Insider activity also saw Director Gregory T. Lucier sell 82,200 shares for over $900,000 in December.
DS World Dubai opens with focus on connected dentistry
DS World Dubai, Dentsply Sirona's international education and networking event, opened its third edition in Dubai, focusing on connected dentistry. The two-day event highlights how digital workflows and intelligent technologies enhance collaboration from diagnosis to restoration, featuring 19 international and regional speakers and an exhibition of Dentsply Sirona solutions.
8.5% Yield From IG-Rated Dentsply Sirona Bonds Still Look Interesting (NASDAQ:XRAY)
Dentsply Sirona Inc. (XRAY), the world's largest supplier of dental products with operations in over 100 countries, has its business segmented across various dental solutions. Despite some performance issues, the company's investment-grade bonds are highlighted as appealing due to their 8.5% current yield. The author's private investing community, Conservative Income Portfolio, was privy to this idea in more depth.
Halper Sadeh Investigates Dentsply Sirona Executives for Breach of Fiduciary Duties
Halper Sadeh LLC is investigating Dentsply Sirona Inc. executives for potential breach of fiduciary duties to shareholders, focusing on corporate governance and shareholder rights. The firm offers to represent long-term shareholders on a contingency fee basis to seek reforms and financial recovery. Shareholder participation is encouraged to enhance company transparency and oversight.
Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential corporate governance reforms, the return of funds to the company, or other relief. This action is handled on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees.
Dentsply Sirona Inc - Co And Patterson Dental Renew Distribution Agreement
Dentsply Sirona Inc. and Patterson Dental have renewed their distribution agreement. This announcement was made via a Reuters headline, and the distribution involves products relevant to the dental industry. The news indicates a continuation of their business relationship.
XRAY - Dentsply Sirona Inc Latest Stock News & Market Updates
Dentsply Sirona Inc. (Nasdaq: XRAY) provides updates on its stock performance and market activities. Recent news highlights renewed distribution partnerships with Patterson Dental and Benco Dental, focusing on expanding access to its dental technology portfolio. The company also announced leadership appointments, including Donald Zurbay to the Board of Directors and Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, alongside its Q3 2025 financial results and a quarterly cash dividend.
DENTSPLY SIRONA Inc Renews U.S. Distribution Agreement with Patterson Dental
DENTSPLY SIRONA Inc. (XRAY) announced the renewal of its U.S. distribution agreement with Patterson Dental on January 14, 2026. This partnership aims to boost growth, broaden access to dental technologies, and improve patient care by integrating devices, software, and services. Patterson Dental customers will continue to have full access to Dentsply Sirona's technology portfolio, as both companies prioritize innovation and support for dental professionals.
Dentsply Sirona Renews U.S. Dental Technology Distribution Deal With Patterson
Dentsply Sirona Inc. (XRAY) has renewed its U.S. dental technology distribution agreement with Patterson Dental Co. This partnership ensures Patterson Dental customers continue to access Dentsply Sirona's dental technology solutions, including CEREC systems and imaging systems. The collaboration aims to enhance practice efficiency and patient care through integrated dental technologies.
Digital dentistry deal keeps high-tech tools in more US clinics nationwide
Dentsply Sirona (Nasdaq: XRAY) and Patterson Dental announced the renewal of their U.S. dental technology distribution agreement. This partnership ensures Patterson Dental customers nationwide continue to have access to Dentsply Sirona’s digital dentistry portfolio, including CEREC, Primescan, Axeos, and Orthophos. The agreement aims to accelerate the adoption of integrated, connected dentistry solutions to enhance practice efficiency and patient care.
Dentsply Sirona and Patterson Dental renew U.S. distribution agreement
Dentsply Sirona and Patterson Dental have renewed their U.S. dental technology distribution agreement, continuing a decades-long partnership. This renewal grants Patterson Dental customers access to Dentsply Sirona's full portfolio of dental technology products. Dentsply Sirona, despite a recent stock price decline, maintains a 5.28% dividend yield and is forecasted to return to profitability this year, according to InvestingPro.
High-tech dental tools reach more clinics in Dentsply Sirona–Benco deal
Dentsply Sirona (Nasdaq: XRAY) and Benco Dental have expanded their partnership to allow Benco to offer Dentsply Sirona’s full dental technology portfolio, including CEREC systems and intraoral scanners, to US customers. This collaboration aims to simplify digital adoption in dentistry by combining Benco's customer-focused service with Dentsply Sirona's advanced technologies. To support this, Benco will open dedicated Dentsply Sirona experiences in three CenterPoint showrooms across the US.
Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions
Dentsply Sirona and Benco Dental have expanded their long-standing partnership to include Dentsply Sirona’s full portfolio of dental technology solutions, such as the CEREC system and various imaging systems, in addition to their existing consumables distribution. This collaboration aims to enhance connected dentistry by simplifying digital adoption, improving efficiency, and supporting dental professionals with advanced integrated solutions and services. Benco Dental will also feature dedicated Dentsply Sirona experiences in its CenterPoint showrooms to allow hands-on exploration of these technologies.
